Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?

Date 09 October 2016
Event ESMO 2016 Congress
Session Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?
Topics Cancer Immunology and Immunotherapy
Melanoma and other Skin Tumours
Presenter Jacob Schachter
Authors J. Schachter
  • Ella Institute of Melanoma, Sheba Cancer Research Center, 52621 - Tel Hashomer/IL